A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

This study has been completed.

Study NCT00455507 Information provided by Kyowa Hakko Kirin Pharma, Inc.

First Received: April 2, 2007 Last Updated: October 29, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)